Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ANTHELMINTICS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,369 records · Page 76Linked to original sources
PubMed1984

Effects of three benzimidazole anthelmintics on the ruminal fermentation ability of sheep.

The effects of albendazole, fenbendazole and oxfendazole on the fermentation ability of the rumen were assessed in 12 Dorset sheep, using as parameters volatile fatty acid concentration, percentage digestibility of cellulose in vitro and pH. Although the digestibility of cellulose was affected only at high concentrations, volatile fatty acid concentrations were markedly reduced after treatment. Correlation coefficient analysis revealed a significant correlation between digestibility of cellulose and volatile fatty acids, as well as between volatile fatty acids and pH. Despite an evident decrease in volatile fatty acids and digestibility of cellulose, it is suggested that this does not outweigh the advantages derived from the use of these benzimidazoles.

Albendazole↗
PubMed1985

Persistent anthelmintic activity of ivermectin in cattle.

Two studies are described which demonstrate the persistent activity of ivermectin injected subcutaneously into cattle at 200 micrograms/kg in preventing the establishment of induced infections with the gastrointestinal parasites Ostertagia ostertagi and Cooperia oncophora and the lungworm Dictyocaulus viviparus. These results indicated a reduction in mean worm count compared with the control group for O ostertagi of more than 99, 45 and 94 per cent with a seven, 14 or 21 day interval between treatment with ivermectin and the administration of infective larvae, respectively, in trial 1 and more than 99, more than 99 and 99 per cent at seven, 10 or 14 days, respectively, in trial 2. Corresponding values against C oncophora were 99, 0 and 45 per cent at seven, 14 and 21 days in trial 1 and more than 99, 84 and 31 per cent at seven, 10 and 14 days in trial 2. Against D viviparus, reduction in counts were more than 99, 98 and more than 99 per cent at seven, 14 and 21 days, respectively, in trial 1 and 100, 100 and 100 per cent at seven, 10 and 14 days, respectively, in trial 2. The relevance of these results to the build-up of infective larvae on pasture and infection in cattle is discussed.

Animals↗
PubMed1987

Efficacy of four anthelmintics against benzimidazole-resistant cyathostomes of horses.

In order to confirm benzimidazole resistance as recommended at a workshop of the Commission of the European Communities the isolate 'E' of cyathostome strongyles originating from a stud where benzimidazole resistance had been demonstrated by egg hatch tests and by egg count reduction tests was investigated in two series of critical tests. Each of 11 foals reared strongyle-free was infected with 130,000 third stage cyathostome larvae. One animal remained untreated, two pairs of foals were treated with paste formulations of the (pro)benzimidazoles cambendazole (20 mg/kg bodyweight) or febantel (6 mg/kg bodyweight) and two groups of three foals were given pastes containing the non-benzimidazole drugs pyrantel pamoate (19 mg/kg bodyweight) or ivermectin (0.2 mg/kg bodyweight) either at 101 days (trial 1) or at 59 to 62 days (trial 2) after infection. Strongyles were counted in faecal samples collected daily between treatment and post mortem examination five or seven days later and worm burdens were counted in the intestinal contents and mucosal digests. Nine species of the cyathostome subfamily were found in the infected foals. The numbers of luminal stages were reduced by only 3.1 and 20.2 (mean 7.9) per cent by cambendazole and by 13.6 and 32.8 (mean 21.3) per cent by febantel in the individual animals. However, pyrantel pamoate (93.6 to 98.2, mean 96.3 per cent reduction) and ivermectin (100 per cent reduction) were highly effective. These trials provide the first report of benzimidazole resistant Cylicostephanus poculatus anywhere in the world and demonstrate (pro)benzimidazole resistance in seven other species for the first time in Europe.

Animals↗
PubMed1987

Preventive anthelmintic treatment of grazing young cattle via supplementary feed and drinking water.

Twenty-six first season calves were allocated into four groups which were turned out on May 21 to graze separate permanent pastures. One group (group A) remained untreated. The others were treated each month with albendazole either as an oral drench (group B) through supplementary feed (group C) or through the drinking water (group D). Neither clinical disease nor weight gain depressions were observed in any group. Although the infection levels were low, the faecal excretion of trichostrongylus eggs, the serum pepsinogen activities and the pasture larval contamination all indicated a marked reduction in the levels of infection of groups B, C and D. The serum pepsinogen activities of groups B and C were similar and remained below 1 unit of tyrosine/litre of serum whereas that of group D was intermediate between these two groups and group A. The labour saving principle which was applied to group C is recommended under conditions similar to those of the present experiment.

Administration, Oral↗